MCRB - Seres Therapeutics GAAP EPS of -$0.89 beats by $0.10 revenue of $126.33M beats by $0.23M
2024-03-05 07:03:41 ET
More on Seres Therapeutics
- Seres Therapeutics' Balancing Act: Breakthrough IP And Financing Concerns
- Seres Therapeutics reports VOWST prelim. Q4 sales of $10.4M; shares jump
- Seeking Alpha’s Quant Rating on Seres Therapeutics
- Historical earnings data for Seres Therapeutics
- Financial information for Seres Therapeutics